abs281.txt	there	is	a	rising	evidence	that	the	proverbial	statement		no	pain	gain	firstcoined	at	light	of	pioneering	clinical	experiences	with	canonicalchemotherapy	still	holds	true	in	era	modern	treatments	cancer	thisclose	relationship	between	occurrence	specific	drug-related	toxicity	andtreatment	outcome	has	been	confirmed	since	then	large	variety	oftreatments	ranging	from	cytotoxics	hormonotherapy	targeted	therapy	and	muchinterestingly	even	latest	immune	checkpoint	inhibitors	currentcontext	precision	medicine	along	constant	quest	for	identifyingpredictive	biomarkers	close	monitoring	treatment-related	toxicities	couldtherefore	be	convenient	to	help	predicting	therapeutic	response	but	presentsseveral	caveats	purpose	this	review	briefly	describe	theserelationships	across	different	comment	on	possible	underlyingmechanisms	strategies	aiming	exploiting	thisrelationship	while	keeping	maximal	safety	ensured	patients	inparticular	will	investigate	how	drug	exposure	germinaland	somatic	genetic	issues	does	impact	aphorism	andwhy	temptation	use	as	cheap	convenientway	predict	or	adapt	dosing	should	resisted	we	doadvocate	instead	developing	comprehensive	genomic	support	withextensive	biomathematical	modeling	better	customize	shift	towards	anew	paradigm
